Veenendaal, November 9th, 2021 -- MolGen B.V., of Veenendaal (NL) is preparing to attend Medica Fair GE, November 15-18. Medica, the largest medical trade fair in the world, has been taking place for more than four decades. Over the years, this event has attracted several thousand exhibitors from more than 50 countries. Furthermore, each year, leading individuals from the fields of business, research, and politics attend this top-class event — alongside tens of thousands of national and international experts and decision-makers from the sector. MolGen is looking forward to the opportunity to be a part of this unique, collaborative environment in which it can connect with global leaders in clinical chemistry, molecular diagnostics, translational medicine, lab management, and other areas of breaking science in laboratory medicine.

MolGen plans to use the event as an opportunity to share its fast-growing brand with market leaders from various industries and showcase and demonstrate its latest products and services. During the event, MolGen will reveal how it has evolved its offerings to include technology, systems, reagents and consumables for human diagnostics and pharmaceutical sciences.

In the area of human diagnostics and pharmaceutical sciences, MolGen develops and globally markets an advanced automated total solution for molecular workflows. Its extraction and testing solutions, products and equipment are designed to achieve increased automation, reduced time to result, high yields and reproducibility. Here, the company is revolutionizing research by providing highly accurate, fast throughput, easy to handle, reliable systems and products for next-generation research genetics that will improve the health and well-being of all.

This event coincides with the opening of MolGen’s recently opened US-based office in San Diego and its UK office in London. MolGen’s success over the past several years has strengthened the company’s resolve to find even more avenues for partnership.

“Attending such a fantastic, innovative event will be the perfect opportunity to share our revolutionary set-ups and customisable workflows that help those in emerging markets conduct safer and economical diagnostics that ultimately improve the lives of people, animals, plants and our planet,” said Niels Kruize, MolGen CCO.

About MolGen
MolGen is a global total solution provider of innovative extraction DNA/RNA technology, systems, products and kits for human and animal diagnostics, the agriculture and biotech industries. MolGen’s, systems, reagents and consumables reduce hands-on time and increase productivity while maintaining high yields and reproducibility. From sample to result, MolGen is challenging the status quo in molecular diagnostics by offering platform stand-alone systems and consumables. MolGen’s portfolio offers high-quality, adaptable, and safe workflows, which can be customised to meet customers’ specific needs.

Learn more about MolGen at www.molgen.com.

Media Contact
Meya Sollman, Marketing Manager
Meya.Sollman@Molgen.com
0031-6-43570635